Continuing Education Information
© 2019 Harborside™
Immuno-Oncology Therapy Essentials: Proactive Management of Immune-Related Adverse Events
Table of Contents
- Immuno-Oncology Essentials: An Overview
- Meeting the Challenge of Immune-Related Adverse Events With Optimized Telephone Triage and Dedicated Oncology Acute Care
- PD-1/PD-L1 Inhibitors for Non–Small Cell Lung Cancer: Incorporating Care Step Pathways for Effective Side-Effect Management
- Checkpoint Inhibitor Immunotherapy for Head and Neck Cancer: Incorporating Care Step Pathways for Effective Side-Effect Management
- Immune-Related Adverse Events From Immunotherapy: Incorporating Care Step Pathways to Improve Management Across Tumor Types
- Appendix: Care Step Pathway Tools for Immune-Related Adverse Event Assessment and Management
A continuing education activity for nurse practitioners, PAs, clinical nurse specialists, advanced degree nurses, oncology and hematology nurses, pharmacists, and physicians.
Release date: March 21, 2019
Expiration date: March 21, 2020
Estimated time to complete activity: 3.0 hours
Certified for CE by:
Annenberg Center for Health Sciences at Eisenhower
39000 Bob Hope Drive, Dinah Shore Bldg.
Rancho Mirage, CA 92270
AIM With Immunotherapy Foundation
139 Waterside Circle
San Rafael, CA 94903
Journal of the Advanced Practitioner in Oncology
94 North Woodhull Road
Huntington, NY 11743
Terranova Medica, LLC
564 Vista Grande Drive
Colorado Springs, CO 80906
© 2019, Annenberg Center for Health Sciences at Eisenhower. All rights reserved.
This certified activity is supported by an educational grant from
Merck & Co., Inc.
Marianne J. Davies, DNP, MSN, RN, APRN, CNS-BC, ACNP-BC, AOCNP®, Yale School of Nursing, Yale University, New Haven, Connecticut
Casey Fazer, PA-C, Mayo Clinic, Rochester, Minnesota
Brianna Hoffner, MSN, ANP-BC, AOCNP® (Chairperson), University of Colorado Cancer Center, Aurora
Krista M. Rubin, MS, FNP-BC, Center for Melanoma, Massachusetts General Hospital, Boston, Massachusetts
Laura S. Wood, RN, MSN, OCN®, Cleveland Clinic Cancer Center, Cleveland, Ohio
The activity’s target audience will consist of nurse practitioners, physician assistants, clinical nurse specialists, advanced degree nurses, oncology and hematology nurses, pharmacists, and physicians.
Activity Rationale and Purpose
The management of immune-related adverse events (irAEs) represents a major challenge for the oncology advanced practice provider. This supplement illustrates the application of the Immuno-Oncology Essentials resources across tumor types, with a particular emphasis on incorporation of the Care Step Pathways (CSPs) for identification, grading, and management of irAEs. These articles highlight the essential role of the advanced practice provider for educating patients and owning the triage, identification, and management of irAEs.
After completing this educational activity, participants should be able to:
- Discuss the use of immune checkpoint inhibitors across tumor types
- Evaluate staff and institutional resources involved with the adequate triage of immune-related adverse events associated with immune checkpoint inhibitors
- Identify, grade, and manage irAEs associated with immune checkpoint inhibitors
- Educate and counsel patients to be active participants in the identification and management of immune-related adverse events associated with immune checkpoint inhibitors
Statement of Credit—Participants who successfully complete this activity (including the submission of the post-test and evaluation form) will receive a statement of credit.
Physicians. This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the Annenberg Center for Health Sciences at Eisenhower, the Advanced Practitioner Society for Hematology and Oncology, and the Journal of the Advanced Practitioner in Oncology. The Annenberg Center is accredited by the ACCME to provide continuing medical education for physicians.
The Annenberg Center for Health Sciences at Eisenhower designates this enduring activity for a maximum of 3.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses. The Annenberg Center for Health Sciences at Eisenhower is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
A maximum of 3.0 contact hours, which includes 2.5 hours of pharmacology, may be earned for successful completion of this activity.
Provider approved by the California Board of Registered Nursing, Provider No. 13664, for 3.0 contact hours.
Pharmacists. The Annenberg Center for Health Sciences at Eisenhower is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This program has been assigned ACPE Universal Program #0797-9999-19-019-H01-P. This program is designated for up to 3.0 contact hours (0.30 CEUs) of continuing pharmacy education credit.
All individuals in positions to control the content of this program (e.g., planners, faculty, content reviewers) are expected to disclose all financial relationships with commercial interests that may have a direct bearing on the subject matter of this continuing education activity. Annenberg Center for Health Sciences at Eisenhower has identified and resolved all conflicts of interest in accordance with the ACHS policies and procedures. Participants have the responsibility to assess the impact (if any) of the disclosed information on the educational value of the activity.
Marianne J. Davies, DNP, MSN, RN, APRN, CNS-BC, ACNP-BC, AOCNP®, has served on speakers bureaus for AstraZeneca, Bristol-Myers Squibb, Genentech, and Merck.
Casey Fazer, PA-C, has nothing to disclose.
Brianna Hoffner, MSN, ANP-BC, AOCNP® (Chairperson), has served on advisory boards for Bristol-Myers Squibb and Merck.
Krista M. Rubin, MS, FNP-BC, has served on advisory boards for Bristol-Myers Squibb and Merck.
Laura S. Wood, RN, MSN, OCN®, has served on speakers bureaus for Bristol-Myers Squibb, Genentech,
ANNENBERG CENTER FOR HEALTH SCIENCES AT EISENHOWER
Staff at the Annenberg Center for Health Sciences at Eisenhower have no relevant commercial relationships to disclose.
Lead Nurse Planner
Dorothy Caputo, MA, BSN, RN, has nothing to disclose.
Harborside staff have no potential conflicts of interest to disclose.
Terranova Medica LLC
Michael Coco, PhD, has nothing to disclose.
Sharon Cross, PhD, has nothing to disclose.
Lisa Tushla, PhD, H(ASCP), has nothing to disclose.
Andrea Edwards, PA-C, has served as a speaker for Pfizer.
Nancy Nix, PharmD, BCPS, BCOP, has nothing to disclose.
Pamela Viale, RN, MS, CNS, ANP, has nothing to disclose.
Laura Zitella, MS, RN, ACNP-BC, AOCN®, has served as a consultant for AbbVie, Amgen, Array BioPharma, AstraZeneca, Gilead, and Merck.
This activity has been designed to provide continuing education that is focused on specific objectives. In selecting educational activities, clinicians should pay special attention to the relevance of those objectives and the application to their particular needs. The intent of all Annenberg Center for Health Sciences at Eisenhower educational opportunities is to provide learning that will improve patient care. Clinicians are encouraged to reflect on this activity and its applicability to their own patient population.
The opinions expressed in this activity are those of the faculty and reviewers and do not represent an endorsement by Annenberg Center for Health Sciences at Eisenhower of any specific therapeutics or approaches to diagnosis or patient management.
This educational activity may contain discussion of published as well as investigational uses of agents that are not approved by the US Food and Drug Administration. For additional information about approved uses, including approved indications, contraindications, and warnings, please refer to the prescribing information for each product.
How to Earn Credit
To qualify for CE credit, you must read all 6 articles in this supplement. To access the learning assessment and evaluation form online, visit
Statement of Credit: Participants who successfully complete this activity (including scoring of a minimum of 70% on the learning assessment) and complete and submit the evaluation form will be able to download a statement of credit.